PKC inhibitors: potential in T cell-dependent immune diseases

Current Opinion in Cell Biology

Volumn 21, Issue 2, 2009, Pages 262-267

  Baier, Gottfried ^a   Wagner, Jürgen ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BISINDOLYLMALEIMIDE; IMMUNOSUPPRESSIVE AGENT; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C GAMMA; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; SOTRASTAURIN; STAUROSPORINE DERIVATIVE;

ADAPTIVE IMMUNITY; CELL ADHESION; CYTOKINE PRODUCTION; DRUG ACTIVITY; ENZYME ACTIVITY; IMMUNOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CELL ADHESION; CYTOKINES; HUMANS; IMMUNE SYSTEM DISEASES; ISOENZYMES; LYMPHOCYTE ACTIVATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 64149122243     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2008.12.008     Document Type: Review

References (54)

1. Krawczyk C., and Penninger J.M. Molecular controls of antigen receptor clustering and autoimmunity. Trends Cell Biol 11 (2001) 212-220
2. Crabtree G.R., and Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 109 Suppl. (2002) S67-S79
3. Macian F., Lopez-Rodriguez C., and Rao A. Partners in transcription: NFAT and AP-1. Oncogene 20 (2001) 2476-2489
4. Schmitz M.L., and Krappmann D. Controlling NF-κB activation in T cells by costimulatory receptors. Cell Death Differ 13 (2006) 834-842
5. Weaver C.T., Hatton R.D., Mangan P.R., and Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25 (2007) 821-852
6. Zheng Y., Zha Y., and Gajewski T.F. Molecular regulation of T cell anergy. EMBO Rep 9 (2008) 50-55
7. Marsland B.J., and Kopf M. T cell fate and function: PKC θ and beyond. Trends Immunol 29 (2008) 179-185
8. Sun Z., Arendt C.W., Ellmeier W., Schaeffer E.M., Sunshine M.J., Gandhi L., Annes J., Petrzilka D., Kupfer A., Schwartzberg P.L., et al. PKC θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404 (2000) 402-407
9. -/- mice. J Immunol 176 (2006) 6004-6011
10. 2+ mobilization and NFAT activation in primary mouse T cells. J Exp Med 197 (2003) 1525-1535
11. 2+ signaling by PKC θ in restimulated T cells via a Tec kinase-dependent pathway. Eur J Immunol 34 (2004) 2001-2011
12. Letschka T., Kollmann V., Pfeifhofer-Obermair C., Lutz-Nicoladoni C., Obermair G.J., Fresser F., Leitges M., Hermann-Kleiter N., Kaminski S., and Baier G. PKC θ selectively controls the adhesion-stimulating molecule Rap1. Blood 112 (2008) 4617-4627. Using molecular cell biology approaches as well as PKC isotype-deficient T cells, this study for the first time implicates PKCθ in TCR-induced Rap1 activation and LFA-1 mediated T cell adhesiveness.
13. Vincenti F., and Kirk A.D. What's next in the pipeline. Am J Transplant 8 (2008) 1972-1981
14. Skvara H., Dawid M., Kleyn E., Wolff B., Meingassner J.G., Knight H., Dumortier T., Kopp T., Fallahi N., Stary G., et al. The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J Clin Invest 118 (2008) 3151-3159. This is the first study that demonstrates that treatment with a PKC inhibitor may improve the symptoms of patients suffering from severe psoriasis. Long-term studies will be required as a follow-up to this two-week proof-of-concept study to fully assess safety and efficacy of AEB071.
15. Takai Y., Kishimoto A., Inoue M., and Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 252 (1977) 7603-7609
16. Steinberg S.F. Structural basis of protein kinase C isoform function. Physiol Rev 88 (2008) 1341-1378
17. Kofler K., Erdel M., Utermann G., and Baier G. Molecular genetics and structural genomics of the human protein kinase C gene module. Genome Biol (2002) 3
18. Newton AC: Lipid activation of protein kinases. J Lipid Res 2008 Nov 24. [Epub ahead of print] PMID: 19033211.
19. Gallegos L.L., and Newton A.C. Spatiotemporal dynamics of lipid signaling: protein kinase C as a paradigm. IUBMB Life 60 (2008) 782-789
20. Baier G., Telford D., Giampa L., Coggeshall K.M., Baier-Bitterlich G., Isakov N., and Altman A. Molecular cloning and characterization of PKC θ, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem 268 (1993) 4997-5004
21. Baier-Bitterlich G., Uberall F., Bauer B., Fresser F., Wachter H., Grunicke H., Utermann G., Altman A., and Baier G. Protein kinase C θ isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol 16 (1996) 1842-1850
22. Altman A., Isakov N., and Baier G. Protein kinase C θ: a new essential superstar on the T cell stage. Immunol Today 21 (2000) 567-573
23. Monks C.R., Kupfer H., Tamir I., Barlow A., and Kupfer A. Selective modulation of PKC θ during T cell activation. Nature 385 (1997) 83-86
24. + T lymphocytes. Blood 107 (2006) 4841-4848
25. Thuille N., Heit I., Fresser F., Krumbock N., Bauer B., Leuthaeusser S., Dammeier S., Graham C., Copeland T.D., Shaw S., et al. Critical role of novel Thr-219 autophosphorylation for the cellular function of PKC θ in T lymphocytes. EMBO J 24 (2005) 3869-3880
26. Gruber T., Freeley M., Thuille N., Heit I., Shaw S., Long A., and Baier G. Comment on 'PDK1 nucleates T cell receptor-induced signaling complex for NF-κB activation'. Science 312 (2006) 55
27. Thuille N., Gruber T., Bock G., Leitges M., and Baier G. Protein kinase C β is dispensable for TCR-signaling. Mol Immunol 41 (2004) 385-390
28. Volkov Y., Long A., McGrath S., Ni Eidhin D., and Kelleher D. Crucial importance of PKC β(I) in LFA-1-mediated locomotion of activated T cells. Nat Immunol 2 (2001) 508-514
29. + T cells. Immunol Lett 96 (2005) 291-293
30. Gruber T., Fresser F., Jenny M., Uberall F., Leitges M., and Baier G. PKC θ cooperates with atypical PKC ζ and PKC ι in NF-κB transactivation of T lymphocytes. Mol Immunol (2007)
31. Gruber T., Thuille N., Hermann-Kleiter N., Leitges M., and Baier G. Protein kinase C ε is dispensable for TCR/CD3-signaling. Mol Immunol 42 (2005) 305-310
32. Martin P., Villares R., Rodriguez-Mascarenhas S., Zaballos A., Leitges M., Kovac J., Sizing I., Rennert P., Marquez G., Martinez A.C., et al. Control of Th2 cell function and allergic airway inflammation by PKC ζ. Proc Natl Acad Sci U S A 102 (2005) 9866-9871
33. Guo B., Su T.T., and Rawlings D.J. Protein kinase C family functions in B cell activation. Curr Opin Immunol 16 (2004) 367-373
34. Tan S.L., and Parker P.J. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem J 376 (2003) 545-552
35. Wilda M., Ghaffari-Tabrizi N., Reisert I., Utermann G., Baier G., and Hameister H. Protein kinase C isoenzymes: selective expression pattern of protein kinase C θ; during mouse development. Mech Dev 103 (2001) 197-200
36. Hayashi K., and Altman A. Protein kinase C θ (PKCθ): a key player in T cell life and death. Pharmacol Res 55 (2007) 537-544
37. + T cell survival is regulated differentially by protein kinase C θ, c-Rel, and protein kinase B. J Immunol 178 (2007) 2932-2939
38. Hermann-Kleiter N., Gruber T., Lutz-Nicoladoni C., Thuille N., Fresser F., Labi V., Schiefermeier N., Warnecke M., Huber L., Villunger A., et al. The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity. Immunity 29 (2008) 205-216. In this study orphan receptor NR2F6, a direct substrate and effector of PKC, is established as transcriptional repressor to NFAT/AP-1 and subsequently IL-17 transcription and Nr2f6-deficient mice have hyper-reactive lymphocytes and develop autoimmune pathology.
39. Burbach B.J., Medeiros R.B., Mueller K.L., and Shimizu Y. T cell receptor signaling to integrins. Immunol Rev 218 (2007) 65-81
40. Menasche G., Kliche S., Bezman N., and Schraven B. Regulation of T cell antigen receptor-mediated inside-out signaling by cytosolic adapter proteins and Rap1 effector molecules. Immunol Rev 218 (2007) 82-91
41. Salek-Ardakani S., So T., Halteman B.S., Altman A., and Croft M. Protein kinase C θ controls Th1 cells in experimental autoimmune encephalomyelitis. J Immunol 175 (2005) 7635-7641
42. Tan S.L., Zhao J., Bi C., Chen X.C., Hepburn D.L., Wang J., Sedgwick J.D., Chintalacharuvu S.R., and Na S. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C θ-deficient mice. J Immunol 176 (2006) 2872-2879
43. Salek-Ardakani S., So T., Halteman B.S., Altman A., and Croft M. Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase C θ. J Immunol 173 (2004) 6440-6447
44. Nagahama K., Ogawa A., Shirane K., Shimomura Y., Sugimoto K., and Mizoguchi A. Protein kinase C θ plays a fundamental role in different types of chronic colitis. Gastroenterology 134 (2008) 459-469. This is the first study showing a role of PKC θ in experimental colitis, a mouse model similar to inflammatory bowel disease.
45. Healy A.M., Izmailova E., Fitzgerald M., Walker R., Hattersley M., Silva M., Siebert E., Terkelsen J., Picarella D., Pickard M.D., et al. PKC θ-deficient mice are protected from Th1-dependent antigen-induced arthritis. J Immunol 177 (2006) 1886-1893
46. Giannoni F., Lyon A.B., Wareing M.D., Dias P.B., and Sarawar S.R. Protein kinase C θ is not essential for T cell-mediated clearance of murine γ-herpesvirus 68. J Virol 79 (2005) 6808-6813
47. Manicassamy S., Yin D., Zhang Z., Molinero L.L., Alegre M.L., and Sun Z. A critical role for protein kinase C θ-mediated T cell survival in cardiac allograft rejection. J Immunol 181 (2008) 513-520. This is the first study showing a role of PKC θ in alloreactivity and graft survival of experimental organ transplants.
48. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., and Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem J 408 (2007) 297-315
49. Karaman M.W., Herrgard S., Treiber D.K., Gallant P., Atteridge C.E., Campbell B.T., Chan K.W., Ciceri P., Davis M.I., Edeen P.T., et al. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 26 (2008) 127-132. The most comprehensive study of kinase selectivity to date including >50% of the predicted human protein kinome. The interaction maps of 38 kinase inhibitors that are marketed or in late stage developed reveal very diverse interaction patterns.
50. Donnelly R., Idris I., and Forrester J.V. Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research. Br J Ophthalmol 88 (2004) 145-151
51. Xu Z.B., Chaudhary D., Olland S., Wolfrom S., Czerwinski R., Malakian K., Lin L., Stahl M.L., Joseph-McCarthy D., Benander C., et al. Catalytic domain crystal structure of PKC θ. J Biol Chem 279 (2004) 50401-50409
52. Grodsky N., Li Y., Bouzida D., Love R., Jensen J., Nodes B., Nonomiya J., and Grant S. Structure of the catalytic domain of human protein kinase C β II complexed with a bisindolylmaleimide inhibitor. Biochemistry 45 (2006) 13970-13981
53. Cywin C.L., Dahmann G., Prokopowicz III A.S., Young E.R., Magolda R.L., Cardozo M.G., Cogan D.A., Disalvo D., Ginn J.D., Kashem M.A., et al. Discovery of potent and selective PKC θ inhibitors. Bioorg Med Chem Lett 17 (2007) 225-230
54. Cole D.C., Asselin M., Brennan A., Czerwinski R., Ellingboe J.W., Fitz L., Greco R., Huang X., Joseph-McCarthy D., Kelly M.F., et al. Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C θ inhibitors. J Med Chem 51 (2008) 5958-5963. In this study, the discovery of a novel class of PKC inhibitors is described. The optimized compounds are selective for PKC θ over the other isotypes and a range of serine/threonine or tyrosine kinases.